These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 11104831

  • 1. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB, Koek W.
    Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831
    [Abstract] [Full Text] [Related]

  • 2. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 17; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 17; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 8. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K.
    Neurosci Res; 1998 May 07; 31(1):23-9. PubMed ID: 9704975
    [Abstract] [Full Text] [Related]

  • 9. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ.
    Psychopharmacology (Berl); 2000 Sep 07; 152(1):55-66. PubMed ID: 11041316
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ, Moerschbaecher JM.
    Behav Pharmacol; 2000 Nov 07; 11(7-8):535-53. PubMed ID: 11198126
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B.
    Eur J Pharmacol; 1997 May 01; 325(2-3):145-53. PubMed ID: 9163561
    [Abstract] [Full Text] [Related]

  • 13. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM, Wallsten CE, Jerning E, Hu PS, Deveney AM.
    Psychopharmacology (Berl); 1998 Oct 01; 139(4):300-10. PubMed ID: 9809851
    [Abstract] [Full Text] [Related]

  • 14. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A, Verrièle L, Chaput C, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 01; 357(3):205-17. PubMed ID: 9550290
    [Abstract] [Full Text] [Related]

  • 15. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J, Meltzer HY.
    Brain Res; 2000 Mar 10; 858(2):252-63. PubMed ID: 10708676
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.
    Routledge C, Gurling J, Wright IK, Dourish CT.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):195-202. PubMed ID: 8223894
    [Abstract] [Full Text] [Related]

  • 18. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.
    Hajós-Korcsok E, Sharp T.
    Eur J Pharmacol; 1996 Oct 31; 314(3):285-91. PubMed ID: 8957248
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
    Newman-Tancredi A, Chaput C, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1996 Jun 20; 307(1):107-11. PubMed ID: 8831111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.